We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
During an FDAnews audioconference on the FDA’s new draft guidance on validation, “Process Validation for the 21st Century: How to Prepare for the FDA’s First Changes in Two Decades,” Alex Kanarek, senior consultant with BioProcess Technology Consultants, answers the following questions about how the guidance affects drugmakers.